ORALLY AVAILABLE VIRIDIOFUNGIN DERIVATIVE POSSESSING ANTI-HCV ACTIVITY
申请人:Chugai Seiyaku Kabushiki Kaisha
公开号:US20150210666A1
公开(公告)日:2015-07-30
An object of the present invention is to provide a compound that is useful as an orally available anti-HCV agent. The present invention relates to a compound represented by formula (1) or a pharmaceutically acceptable salt thereof. This compound has an anti-HCV activity and is useful as a medicine.
Peptide werden hergestellt durch Umsetzung von durch eine Nα-Formylgruppe geschützten α-Aminocarbonsäureestern oder Peptidestern als Carboxylkomponente mit α-Aminocarbonsäuren, α-Aminocarbonsäureestern oder α-Aminocarbonsäureamiden als Aminokomponente in Gegenwart einer Serin- oder Thiolprotease.
Synthesis and intramolecular reactions of Tyr-Gly and Tyr-Gly-Gly related 6-O-glucopyranose esters
作者:Lidija Varga-Defterdarović、Gorana Hrlec
DOI:10.1016/j.carres.2003.07.011
日期:2004.1
6-O-(L-Tyrosylglycyl)- and 6-O-(L-tyrosylglycylglycyl)-D-glucopyranose were synthesized by condensation of the pentachlorophenyl esters of the respective di- and tripeptide with fully unprotected D-glucose. The intramolecular reactivity of the sugar conjugates was studied in pyridine-acetic acid and in dry methanol, at various temperatures and for various incubation times. The composition of the incubation